COMP <GO>
MLYS vs ZBIO // EV/EBITDA & P/E VALUATION
Mineralys Therapeutics Inc. (NASDAQ) VS. Zenas BioPharma Inc. (NASDAQ) • 15-METRIC TALLY: MLYS 3
— ZBIO 2
■ METRIC PARITY
LAST: $18.18 (-14.41%) • MKT CAP: $1.88B
valuation
—
LAST: $28.39 (-1.29%) • MKT CAP: $1.87B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MLYS VS. ZBIO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MLYS | ZBIO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -28.40% | -35.00% | +6.60 | MLYS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -7.58% | -9.19% | +1.61 | MLYS | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 100.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 2.79 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 4/9 | -1.00 | ZBIO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.0 | 54.1 | -8.10 | ZBIO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.88B | $1.87B | $3.3M | MLYS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MLYS REV | ZBIO REV | MLYS GROSS % | ZBIO GROSS % | MLYS FCF | ZBIO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $10.0M | — | — | -$142.4M | -$172.4M |
| FY 2024 | $0 | $5.0M | — | — | -$166.3M | -$119.8M |
| FY 2023 | $0 | $50.0M | — | — | -$81.2M | -$30.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MLYS // BETA —
ZBIO // BETA —